Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
81 hedge funds and large institutions have $48M invested in Avid Bioservices, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 14 closing their positions.
86% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 14
56% more capital invested
Capital invested by funds: $30.8M → $48M (+$17.2M)
16% more funds holding
Funds holding: 70 → 81 (+11)
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
45% less call options, than puts
Call options by funds: $269K | Put options by funds: $491K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.68M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.3M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.57M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$868K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$836K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.67M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.73M |
| 3 |
Renaissance Technologies
New York
|
-$767K |
| 4 |
Millennium Management
New York
|
-$480K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$441K |
CDMO Hedge Fund Activity: Q2 2018 in Review
81 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2018, worth a combined $48M — up 56% from $30.8M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CDMO positions and 14 closed out — a net gain of 12 holders — while 17 added to existing stakes and 16 trimmed.
The largest buyer was BlackRock, adding an estimated $8.68M. The largest seller was Kennedy Capital Management, cutting an estimated $6.67M.
- 81 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2018, up from 70 in Q1 2018.
- Funds reported $48M of Avid Bioservices, Inc. Common Stock stock for Q2 2018, up 56% quarter-over-quarter.
- 26 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2018 and 14 closed out, a net change of +12 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2018 was BlackRock, an estimated $8.68M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2018 was Kennedy Capital Management, an estimated $6.67M sold.
Based on aggregated 13F filings for Q2 2018.